SIRIO is enhancing its strategy for small and medium nutrition brands as Lonza’s Sara Lesina joins as GM in Europe.
SIRIO Pharma (SIRIO), a global nutraceutical contract development and manufacturing organization (CDMO), announced on Sept. 9, 2022 that it has appointed Sara Lesina as a new general manager in Europe. Lesina will seek to drive forward a strategy of targeting small and medium brands launching novel nutraceutical formulations.
Lesina previously worked at Lonza as executive director. According to a company press release, Lonza appointed Lesina to further its goal of nurturing new partnerships with large nutrition brands across the major European markets.
“I joined SIRIO because I see the tremendous resources it has – SIRIO has over 200 R&D scientists across its sites – and there are clear synergies with like-minded innovation focused customers,” commented Lesina in the press release. “We anticipate significant growth in the nutra market in next few years as customers see the benefits of working with an agile CDMO partner to help launch products to market faster. The SIRIO value proposition anchored on R&D and formulation capabilities, combined with our global manufacturing footprint, positions us well to tap into this growth by launching new products for customers.”
“Sara brings with her a tremendous global network and what impressed us is the clarity of purpose to establish SIRIO as the contract research and development hub for the most ambitious global brands,” added Rui Yang, vice-president at SIRIO. “Across Europe there is an increasing number of companies launching new products that could reduce their time to market and/or acquisition by working with SIRIO. Sara’s remit will be to help develop locally relevant formulatory options, working as the European conduit to access SIRIO’s global R&D resources.”
Source: SIRIO
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.